ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting. A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting)

Journal of the American College of Cardiology

Volumn 49, Issue 1, 2007, Pages 126-170

  Bates, Eric R ^a,a   Babb, Joseph D ^a   Casey Jr , Donald E ^a   Cates, Christopher U ^a   Duckwiler, Gary R ^a   Feldman, Ted E ^a   Gray, William A ^a   Ouriel, Kenneth ^a   Peterson, Eric D ^a   Rosenfield, Kenneth ^a   Rundback, John H ^a   Safian, Robert D ^a   Sloan, Michael A ^a   White, Christopher J ^a   Harrington, Robert A ^a   Abrams, Jonathan ^a   Anderson, Jeffrey L ^a   Eisenberg, Mark J ^a   Grines, Cindy L ^a   Hlatky, Mark A ^a   Lichtenberg, Robert C ^a   Lindner, Jonathan R ^a   Pohost, Gerald M ^a   Schofield, Richard S ^a   Shubrooks Jr , Samuel J ^a   Stein, James H ^a   Tracy, Cynthia M ^a   Vogel, Robert A ^a   Wesley, Deborah J ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; ATENOLOL; ATORVASTATIN; ATROPINE; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DOPAMINE; GEMFIBROZIL; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; LOW MOLECULAR WEIGHT HEPARIN; PERINDOPRIL; PHENYLEPHRINE; PLACEBO; RAMIPRIL; TICLOPIDINE; WARFARIN;

ACCREDITATION; ANGIOPLASTY; BLEEDING; CARDIOVASCULAR RISK; CAROTID ARTERIOGRAPHY; CAROTID ARTERY DISEASE; CAROTID ARTERY INJURY; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL DECISION MAKING; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; COMBINATION CHEMOTHERAPY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONSENSUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DRUG MEGADOSE; DRUG TREATMENT FAILURE; DYSLIPIDEMIA; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOTENSION; LOADING DRUG DOSE; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; MONOTHERAPY; NEUROLOGIC DISEASE; NEUTROPENIA; OBESITY; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; QUALITY CONTROL; RECOMMENDED DRUG DOSE; REVASCULARIZATION; REVIEW; SMOKING CESSATION; STENT; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 33846101729     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.10.021     Document Type: Review

References (229)

1. Thom T., Haase N., Rosamond W., et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 (2006) e85-e151
2. Kleindorfer D., Panagos P., Pancioli A., et al. Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke 36 (2005) 720-723
3. White H., Boden-Albala B., Wang C., et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 111 (2005) 1327-1331
4. Bamford J., Sandercock P., Dennis M., Burn J., and Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337 (1991) 1521-1526
5. Gorelick P.B. Distribution of atherosclerotic cerebrovascular lesions. Effects of age, race, and sex. Stroke 24 (1993) I16-I19
6. Sacco R.L., Kargman D.E., Gu Q., and Zamanillo M.C. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 26 (1995) 14-20
7. Wityk R.J., Lehman D., Klag M., et al. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 27 (1996) 1974-1980
8. Bogousslavsky J., Van M.G., and Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke 19 (1988) 1083-1092
9. Foulkes M.A., Wolf P.A., Price T.R., et al. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 19 (1988) 547-554
10. Inzitari D., Eliasziw M., Gates P., et al., North American Symptomatic Carotid Endarterectomy Trial Collaborators. The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. N Engl J Med 342 (2000) 1693-1700
11. Timsit S.G., Sacco R.L., Mohr J.P., et al. Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism. Stroke 23 (1992) 486-491
12. Osborn A.G. Diagnostic Cerebral Angiography. 2nd edition (1999), Williams and Wilkins, Philadelphia, PA
13. Casserly I.P., and Yadav J.S. Carotid intervention. In: Casserly I.P., Sachar R., and Yadav J.S. (Eds). Manual of Peripheral Vascular Intervention (2005), Lippincott Williams & Wilkins, Philadelphia, PA 83-109
14. Schneider P. Advanced cerebrovascular arteriography: applications in carotid stenting. In: Schneider P., Bohannon W., and Silva M. (Eds). Carotid Interventions (2004), Marcel Dekker, New York, NY 69-91
15. Mohr J.P., and Gautier J. Internal carotid artery disease. In: Mohr J.P. (Ed). Stroke: Pathophysiology, Diagnosis, and Management (2004), Churchill Livingstone, Philadelphia, PA 75-200
16. Cho L., and Mukherjee D. Basic cerebral anatomy for the carotid interventionalist: The intracranial and extracranial vessels. Catheter Cardiovasc Interv 68 (2006) 104-111
17. White C.J., Ramee S.R., Bendick P.J., and Safian R.D. Peripheral Vascular Intervention: The Manual of Interventional Cardiology. 3rd edition (2001), Physician's Press, Royal Oak, MI 831-901
18. O'Leary D.H., Polak J.F., Kronmal R.A., et al., The CHS Collaborative Research Group. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke 23 (1992) 1752-1760
19. Muluk S.C., Muluk V.S., Sugimoto H., et al. Progression of asymptomatic carotid stenosis: a natural history study in 1004 patients. J Vasc Surg 29 (1999) 208-214
20. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325 (1991) 445-453
21. Barnett H.J., Taylor D.W., Eliasziw M., et al., North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 339 (1998) 1415-1425
22. Rothwell P.M., Warlow C.P., and European Carotid Surgery Trialists' Collaborative Group. Low risk of ischemic stroke in patients with reduced internal carotid artery lumen diameter distal to severe symptomatic carotid stenosis: cerebral protection due to low poststenotic flow?. Stroke 31 (2000) 622-630
23. Morgenstern L.B., Fox A.J., Sharpe B.L., et al., North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. The risks and benefits of carotid endarterectomy in patients with near occlusion of the carotid artery. Neurology 48 (1997) 911-915
24. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273 (1995) 1421-1428
25. Halliday A., Mansfield A., Marro J., et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 363 (2004) 1491-1502
26. Eagle, KA, Guyton, RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery) Available at: http://www.cardiosource.com/guidelines/browse.asp?topicID=7.
27. Benavente O., Eliasziw M., Streifler J.Y., et al. Prognosis after transient monocular blindness associated with carotid-artery stenosis. N Engl J Med 345 (2001) 1084-1090
28. Kappelle L.J., Eliasziw M., Fox A.J., Sharpe B.L., and Barnett H.J. Importance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery. The North American Symptomatic Carotid Endarterectomy Trial. Stroke 30 (1999) 282-286
29. Vernieri F., Pasqualetti P., Matteis M., et al. Effect of collateral blood flow and cerebral vasomotor reactivity on the outcome of carotid artery occlusion. Stroke 32 (2001) 1552-1558
30. Gasecki A.P., Eliasziw M., Ferguson G.G., et al., North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Long-term prognosis and effect of endarterectomy in patients with symptomatic severe carotid stenosis and contralateral carotid stenosis or occlusion: results from NASCET. J Neurosurg 83 (1995) 778-782
31. Henderson R.D., Eliasziw M., Fox A.J., et al., North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Angiographically defined collateral circulation and risk of stroke in patients with severe carotid artery stenosis. Stroke 31 (2000) 128-132
32. Polak J.F., Shemanski L., O'Leary D.H., et al. Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65 years or older. Cardiovascular Health Study. Radiology 208 (1998) 649-654
33. Mathiesen E.B., Bonaa K.H., and Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the tromso study. Circulation 103 (2001) 2171-2175
34. Sitzer M., Muller W., Siebler M., et al. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke 26 (1995) 1231-1233
35. Streifler J.Y., Eliasziw M., Fox A.J., et al. Angiographic detection of carotid plaque ulceration. Comparison with surgical observations in a multicenter study. North American Symptomatic Carotid Endarterectomy Trial. Stroke 25 (1994) 1130-1132
36. Johnston S.C., Gress D.R., Browner W.S., and Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 284 (2000) 2901-2906
37. Lyden P., Raman R., Liu L., et al. NIHSS training and certification using a new digital video disk is reliable. Stroke 36 (2005) 2446-2449
38. Muir K.W., Weir C.J., Murray G.D., et al. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke 27 (1996) 1817-1820
39. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 337 (1991) 1235-1243
40. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351 (1998) 1379-1387
41. Sabeti S., Schillinger M., Mlekusch W., et al. Quantification of internal carotid artery stenosis with duplex US: comparative analysis of different flow velocity criteria. Radiology 232 (2004) 431-439
42. Bray J.M., Galland F., Lhoste P., et al. Colour Doppler and duplex sonography and angiography of the carotid artery bifurcations. Prospective, double-blind study. Neuroradiology 37 (1995) 219-224
43. Bluth E.I., Sunshine J.H., Lyons J.B., et al. Power Doppler imaging: initial evaluation as a screening examination for carotid artery stenosis. Radiology 215 (2000) 791-800
44. Lovett J.K., Redgrave J.N., and Rothwell P.M. A critical appraisal of the performance, reporting, and interpretation of studies comparing carotid plaque imaging with histology. Stroke 36 (2005) 1091-1097
45. Rothwell P.M., Gibson R., Warlow C.P., and European Carotid Surgery Trialists' Collaborative Group. Interrelation between plaque surface morphology and degree of stenosis on carotid angiograms and the risk of ischemic stroke in patients with symptomatic carotid stenosis. Stroke 31 (2000) 615-621
46. Biasi G.M., Froio A., Diethrich E.B., et al. Carotid plaque echolucency increases the risk of stroke in carotid stenting: the Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study. Circulation 110 (2004) 756-762
47. Kastelein J.J., de Groot E., and Sankatsing R. Atherosclerosis measured by B-mode ultrasonography: effect of statin therapy on disease progression. Am J Med 116 Suppl 6A (2004) 31S-36S
48. Hodis H.N., Mack W.J., LaBree L., et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 128 (1998) 262-269
49. Blakeley D.D., Oddone E.Z., Hasselblad V., et al. Noninvasive carotid artery testing. A meta-analytic review. Ann Intern Med 122 (1995) 360-367
50. Grant E.G., Benson C.B., Moneta G.L., et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis-Society of Radiologists in Ultrasound Consensus Conference. Radiology 229 (2003) 340-346
51. Comerota A.J., Salles-Cunha S.X., Daoud Y., et al. Gender differences in blood velocities across carotid stenoses. J Vasc Surg 40 (2004) 939-944
52. AbuRahma A.F., Robinson P.A., Strickler D.L., et al. Proposed new duplex classification for threshold stenoses used in various symptomatic and asymptomatic carotid endarterectomy trials. Ann Vasc Surg 12 (1998) 349-358
53. Busuttil S.J., Franklin D.P., Youkey J.R., and Elmore J.R. Carotid duplex overestimation of stenosis due to severe contralateral disease. Am J Surg 172 (1996) 144-147
54. Fujitani R.M., and Kafie F. Screening and preoperative imaging of candidates for carotid endarterectomy. Semin Vasc Surg 12 (1999) 261-274
55. Howard G., Baker W.H., Chambless L.E., et al., Asymptomatic Carotid Atherosclerosis Study Investigators. An approach for the use of Doppler ultrasound as a screening tool for hemodynamically significant stenosis (despite heterogeneity of Doppler performance). A multicenter experience. Stroke 27 (1996) 1951-1957
56. Kuntz K.M., Polak J.F., Whittemore A.D., Skillman J.J., and Kent K.C. Duplex ultrasound criteria for the identification of carotid stenosis should be laboratory specific. Stroke 28 (1997) 597-602
57. Alexandrov A.V. Ultrasound and angiography in the selection of patients for carotid endarterectomy. Curr Cardiol Rep 5 (2003) 141-147
58. Elgersma O.E., van Leersum M., Buijs P.C., et al. Changes over time in optimal duplex threshold for the identification of patients eligible for carotid endarterectomy. Stroke 29 (1998) 2352-2356
59. Qureshi A.I., Suri M.F., Ali Z., et al. Role of conventional angiography in evaluation of patients with carotid artery stenosis demonstrated by Doppler ultrasound in general practice. Stroke 32 (2001) 2287-2291
60. Akers D.L., Markowitz I.A., and Kerstein M.D. The value of aortic arch study in the evaluation of cerebrovascular insufficiency. Am J Surg 154 (1987) 230-232
61. Sitzer M., Rose G., Furst G., et al. Characteristics and clinical value of an intravenous echo-enhancement agent in evaluation of high-grade internal carotid stenosis. J Neuroimaging 7 Suppl 1 (1997) S22-S25
62. Droste D.W., Jurgens R., Weber S., et al. Benefit of echocontrast-enhanced transcranial color-coded duplex ultrasound in the assessment of intracranial collateral pathways. Stroke 31 (2000) 920-923
63. Ferrer J.M., Samso J.J., Serrando J.R., et al. Use of ultrasound contrast in the diagnosis of carotid artery occlusion. J Vasc Surg 31 (2000) 736-741
64. Paciaroni M., Caso V., Cardaioli G., et al. Is ultrasound examination sufficient in the evaluation of patients with internal carotid artery severe stenosis or occlusion?. Cerebrovasc Dis 15 (2003) 173-176
65. Filis K.A., Arko F.R., Johnson B.L., et al. Duplex ultrasound criteria for defining the severity of carotid stenosis. Ann Vasc Surg 16 (2002) 413-421
66. Mattos M.A., Hodgson K.J., Faught W.E., et al. Carotid endarterectomy without angiography: is color-flow duplex scanning sufficient?. Surgery 116 (1994) 776-782
67. Patel M.R., Kuntz K.M., Klufas R.A., et al. Preoperative assessment of the carotid bifurcation. Can magnetic resonance angiography and duplex ultrasonography replace contrast arteriography?. Stroke 26 (1995) 1753-1758
68. Navarro J.C., Mikulik R., Garami Z., and Alexandrov A.V. The accuracy of transcranial Doppler in the diagnosis of stenosis or occlusion of the terminal internal carotid artery. J Neuroimaging 14 (2004) 314-318
69. Sloan M.A., Alexandrov A.V., Tegeler C.H., et al. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 62 (2004) 1468-1481
70. Marshall R.S., Rundek T., Sproule D.M., et al. Monitoring of cerebral vasodilatory capacity with transcranial Doppler carbon dioxide inhalation in patients with severe carotid artery disease. Stroke 34 (2003) 945-949
71. Spence J.D., Tamayo A., Lownie S.P., Ng W.P., and Ferguson G.G. Absence of microemboli on transcranial Doppler identifies low-risk patients with asymptomatic carotid stenosis. Stroke 36 (2005) 2373-2378
72. Wutke R., Lang W., Fellner C., et al. High-resolution, contrast-enhanced magnetic resonance angiography with elliptical centric k-space ordering of supra-aortic arteries compared with selective X-ray angiography. Stroke 33 (2002) 1522-1529
73. Alvarez-Linera J., Benito-Leon J., Escribano J., Campollo J., and Gesto R. Prospective evaluation of carotid artery stenosis: elliptic centric contrast-enhanced MR angiography and spiral CT angiography compared with digital subtraction angiography. Am J Neuroradiol 24 (2003) 1012-1019
74. Remonda L., Senn P., Barth A., et al. Contrast-enhanced 3D MR angiography of the carotid artery: comparison with conventional digital subtraction angiography. Am J Neuroradiol 23 (2002) 213-219
75. Cosottini M., Pingitore A., Puglioli M., et al. Contrast-enhanced three-dimensional magnetic resonance angiography of atherosclerotic internal carotid stenosis as the noninvasive imaging modality in revascularization decision making. Stroke 34 (2003) 660-664
76. DeMarco J.K., Huston III J., and Bernstein M.A. Evaluation of classic 2D time-of-flight MR angiography in the depiction of severe carotid stenosis. AJR Am J Roentgenol 183 (2004) 787-793
77. Long A., Lepoutre A., Corbillon E., and Branchereau A. Critical review of non- or minimally invasive methods (duplex ultrasonography, MR- and CT-angiography) for evaluating stenosis of the proximal internal carotid artery. Eur J Vasc Endovasc Surg 24 (2002) 43-52
78. Buskens E., Nederkoorn P.J., Buijs-Van Der W.T., et al. Imaging of carotid arteries in symptomatic patients: cost-effectiveness of diagnostic strategies. Radiology 233 (2004) 101-112
79. Yuan C., Mitsumori L.M., Ferguson M.S., et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 104 (2001) 2051-2056
80. Rutt B.K., Clarke S.E., and Fayad Z.A. Atherosclerotic plaque characterization by MR imaging. Curr Drug Targets Cardiovasc Haematol Disord 4 (2004) 147-159
81. Glor F.P., Ariff B., Crowe L.A., et al. Carotid geometry reconstruction: a comparison between MRI and ultrasound. Med Phys 30 (2003) 3251-3261
82. Teng M.M., Tsai F., Liou A.J., et al. Three-dimensional contrast-enhanced magnetic resonance angiography of carotid artery after stenting. J Neuroimaging 14 (2004) 336-341
83. Gronholdt M.L. B-mode ultrasound and spiral CT for the assessment of carotid atherosclerosis. Neuroimaging Clin N Am 12 (2002) 421-435
84. Belsky M., Gaitini D., Goldsher D., Hoffman A., and Daitzchman M. Color-coded duplex ultrasound compared to CT angiography for detection and quantification of carotid artery stenosis. Eur J Ultrasound 12 (2000) 49-60
85. Hollingworth W., Nathens A.B., Kanne J.P., et al. The diagnostic accuracy of computed tomography angiography for traumatic or atherosclerotic lesions of the carotid and vertebral arteries: a systematic review. Eur J Radiol 48 (2003) 88-102
86. Koelemay M.J., Nederkoorn P.J., Reitsma J.B., and Majoie C.B. Systematic review of computed tomographic angiography for assessment of carotid artery disease. Stroke 35 (2004) 2306-2312
87. Addis K.A., Hopper K.D., Iyriboz T.A., et al. CT angiography: in vitro comparison of five reconstruction methods. AJR Am J Roentgenol 177 (2001) 1171-1176
88. Chen C.J., Lee T.H., Hsu H.L., et al. Multi-slice CT angiography in diagnosing total versus near occlusions of the internal carotid artery: comparison with catheter angiography. Stroke 35 (2004) 83-85
89. Rothwell P.M., Eliasziw M., Gutnikov S.A., et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 361 (2003) 107-116
90. King-Im J.M., Trivedi R.A., Cross J.J., et al. Measuring carotid stenosis on contrast-enhanced magnetic resonance angiography: diagnostic performance and reproducibility of 3 different methods. Stroke 35 (2004) 2083-2088
91. Connors III J.J., Sacks D., Furlan A.J., et al. Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology, American Association of Neurological Surgeons, American Society of Interventional and Therapeutic Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, AANS/CNS Cerebrovascular Section, and Society of Interventional Radiology. Radiology 234 (2005) 26-34
92. Fayed A.M., White C.J., Ramee S.R., Jenkins J.S., and Collins T.J. Carotid and cerebral angiography performed by cardiologists: cerebrovascular complications. Catheter Cardiovasc Interv 55 (2002) 277-280
93. Leonardi M., Cenni P., Simonetti L., Raffi L., and Battaglia S. Retrospective study of complications arising during cerebral and spinal diagnostic angiography from 1998 to 2003. Interventional Neuroradiology 11 (2005) 213-221
94. Smith S., and Allen J. AHA/ACC secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2005 update. Circulation 113 (2006) 2363-2372
95. Sacco R.L., Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 37 (2006) 577-617
96. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 352 (1998) 1801-1807
97. Vaccarino V., Berger A.K., Abramson J., et al. Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program. Am J Cardiol 88 (2001) 980-986
98. Collins R., Peto R., MacMahon S., et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335 (1990) 827-838
99. Staessen J.A., Gasowski J., Wang J.G., et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 355 (2000) 865-872
100. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
101. Shinton R., and Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 298 (1989) 789-794
102. Wolf P.A., D'Agostino R.B., Kannel W.B., Bonita R., and Belanger A.J. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 259 (1988) 1025-1029
103. You R.X., Thrift A.G., McNeil J.J., Davis S.M., Donnan G.A., and Melbourne Stroke Risk Factor Study (MERFS) Group. Ischemic stroke risk and passive exposure to spouses' cigarette smoking. Am J Public Health 89 (1999) 572-575
104. Kawachi I., Colditz G.A., Stampfer M.J., et al. Smoking cessation and decreased risk of stroke in women. JAMA 269 (1993) 232-236
105. Fine-Edelstein J.S., Wolf P.A., O'Leary D.H., et al. Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology 44 (1994) 1046-1050
106. Amarenco P., Lavallee P., and Touboul P.J. Stroke prevention, blood cholesterol, and statins. Lancet Neurol 3 (2004) 271-278
107. Kuller L.H., Dorman J.S., and Wolf P.A. Cerebrovascular Disease and Diabetes (1985), NIH Publication, Bethesda, MD #85-1468
108. Standards of medical care in diabetes. Diabetes Care 27 Suppl 1 (2004) S15-S35
109. Walker S.P., Rimm E.B., Ascherio A., et al. Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol 144 (1996) 1143-1150
110. Rexrode K.M., Hennekens C.H., Willett W.C., et al. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 277 (1997) 1539-1545
111. Wilhelmsen L., Svardsudd K., Korsan-Bengtsen K., et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311 (1984) 501-505
112. Rost N.S., Wolf P.A., Kase C.S., et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 32 (2001) 2575-2579
113. Boushey C.J., Beresford S.A., Omenn G.S., and Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274 (1995) 1049-1057
114. Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study. Lancet 1 (1981) 541-546
115. Wolf P.A., D'Agostino R.B., Belanger A.J., and Kannel W.B. Probability of stroke: a risk profile from the Framingham Study. Stroke 22 (1991) 312-318
116. The SALT Collaborative Group. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 338 (1991) 1345-1349
117. Farrell B., Godwin J., Richards S., and Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 54 (1991) 1044-1054
118. The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 325 (1991) 1261-1266
119. Taylor D.W., Barnett H.J., Haynes R.B., et al., ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. Lancet 353 (1999) 2179-2184
120. Diener H.C., Cunha L., Forbes C., et al. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143 (1996) 1-13
121. Halkes P.H., van Gijn J., Kappelle L.J., Koudstaal P.J., and Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 367 (2006) 1665-1673
122. Gent M., Blakely J.A., Easton J.D., et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1 (1989) 1215-1220
123. Hass W.K., Easton J.D., Adams Jr. H.P., et al., Ticlopidine Aspirin Stroke Study Group. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 321 (1989) 501-507
124. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 (1996) 1329-1339
125. Diener H.C., Bogousslavsky J., Brass L.M., et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364 (2004) 331-337
126. Bhatt D.L., Fox K.A., Hacke W., et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354 (2006) 1706-1717
127. Mohr J.P., Thompson J.L., Lazar R.M., et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 345 (2001) 1444-1451
128. Chimowitz M.I., Kokkinos J., Strong J., et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 45 (1995) 1488-1493
129. Ridker P.M., Cook N.R., Lee I.M., et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 352 (2005) 1293-1304
130. Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
131. Albers G.W., Amarenco P., Easton J.D., et al. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 483S-512S
132. Rubins H.B., Robins S.J., Collins D., et al., Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med 341 (1999) 410-418
133. Canner P.L., Berge K.G., Wenger N.K., et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 8 (1986) 1245-1255
134. Collins R., Armitage J., Parish S., et al. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 363 (2004) 757-767
135. Sever P.S., Dahlof B., Poulter N.R., et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361 (2003) 1149-1158
136. White H.D., Simes R.J., Anderson N.E., et al. Pravastatin therapy and the risk of stroke. N Engl J Med 343 (2000) 317-326
137. McGirt M.J., Perler B.A., Brooke B.S., et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg 42 (2005) 829-836
138. Amarenco P., Bogousslavsky J., Callahan A., et al. Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study. Cerebrovasc Dis 16 (2003) 389-395
139. Amarenco P., Bogousslavsky J., Callahan III A.S., et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355 (2006) 549-559
140. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 (2004) 227-239
141. Statins after ischemic stroke and transient ischemic attack: an advisory statement from the Stroke Council, American Heart Association and American Stroke Association. Stroke 35 (2004) 1023
142. Yusuf S., Sleight P., Pogue J., et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 (2000) 145-153
143. Lonn E., Yusuf S., Dzavik V., et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 103 (2001) 919-925
144. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358 (2001) 1033-1041
145. Lindholm L.H., Ibsen H., Dahlof B., et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359 (2002) 1004-1010
146. Fisher M. Occlusion of the internal carotid artery. AMA Arch Neurol Psychiatry 65 (1951) 346-377
147. DeBakey M.E. Successful carotid endarterectomy for cerebrovascular insufficiency. Nineteen-year follow-up. JAMA 233 (1975) 1083-1085
148. Eastcott H.H., Pickering G.W., and Rob C.G. Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia. Lancet 267 (1954) 994-996
149. The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 313 (1985) 1191-1200
150. Chambers B.R., and Norris J.W. The case against surgery for asymptomatic carotid stenosis. Stroke 15 (1984) 964-967
151. Mayberg M.R., Wilson S.E., Yatsu F., et al., Veterans Affairs Cooperative Studies Program 309 Trialist Group. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. JAMA 266 (1991) 3289-3294
152. Hobson R.W., Weiss D.G., Fields W.S., et al., The Veterans Affairs Cooperative Study Group. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 328 (1993) 221-227
153. Tangkanakul C., Counsell C.E., and Warlow C.P. Local versus general anaesthesia in carotid endarterectomy: a systematic review of the evidence. Eur J Vasc Endovasc Surg 13 (1997) 491-499
154. Cao P., De Rango P., and Zannetti S. Eversion vs conventional carotid endarterectomy: a systematic review. Eur J Vasc Endovasc Surg 23 (2002) 195-201
155. Ferguson G.G., Eliasziw M., Barr H.W., et al. The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke 30 (1999) 1751-1758
156. Baker W.H., Littooy F.N., Hayes A.C., Dorner D.B., and Stubbs D. Carotid endarterectomy without a shunt: the control series. J Vasc Surg 1 (1984) 50-56
157. Gnanadev D.A., Wang N., Comunale F.L., and Reile D.A. Carotid artery stump pressure: how reliable is it in predicting the need for a shunt?. Ann Vasc Surg 3 (1989) 313-317
158. Schneider J.R., Droste J.S., Schindler N., et al. Carotid endarterectomy with routine electroencephalography and selective shunting: influence of contralateral internal carotid artery occlusion and utility in prevention of perioperative strokes. J Vasc Surg 35 (2002) 1114-1122
159. Counsell C.E., Salinas R., Naylor R., and Warlow C.P. A systematic review of the randomised trials of carotid patch angioplasty in carotid endarterectomy. Eur J Vasc Endovasc Surg 13 (1997) 345-354
160. Ouriel K., and Green R.M. Clinical and technical factors influencing recurrent carotid stenosis and occlusion after endarterectomy. J Vasc Surg 5 (1987) 702-706
161. Grego F., Antonello M., Lepidi S., et al. Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. J Vasc Surg 38 (2003) 1232-1240
162. O'Hara P.J., Hertzer N.R., Mascha E.J., et al. A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. J Vasc Surg 35 (2002) 324-332
163. Bond R., Rerkasem K., and Rothwell P.M. Systematic review of the risks of carotid endarterectomy in relation to the clinical indication for and timing of surgery. Stroke 34 (2003) 2290-2301
164. Bond R., Rerkasem K., Shearman C.P., and Rothwell P.M. Time trends in the published risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Cerebrovasc Dis 18 (2004) 37-46
165. Feasby T.E., Quan H., and Ghali W.A. Hospital and surgeon determinants of carotid endarterectomy outcomes. Arch Neurol 59 (2002) 1877-1881
166. Pearce W.H., Parker M.A., Feinglass J., Ujiki M., and Manheim L.M. The importance of surgeon volume and training in outcomes for vascular surgical procedures. J Vasc Surg 29 (1999) 768-776
167. Chambers B., Donnan G., and Chambers B. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev (2005) CD001923
168. Barnett H.J., Eliasziw M., Meldrum H.E., and Taylor D.W. Do the facts and figures warrant a 10-fold increase in the performance of carotid endarterectomy on asymptomatic patients?. Neurology 46 (1996) 603-608
169. Hsia D.C., Moscoe L.M., and Krushat W.M. Epidemiology of carotid endarterectomy among Medicare beneficiaries: 1985-1996 update. Stroke 29 (1998) 346-350
170. Wennberg D.E., Lucas F.L., Birkmeyer J.D., Bredenberg C.E., and Fisher E.S. Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA 279 (1998) 1278-1281
171. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 357 (2001) 1729-1737
172. Yadav J.S., Wholey M.H., Kuntz R.E., et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351 (2004) 1493-1501
173. Chaturvedi S. Should the multicenter carotid endarterectomy trials be repeated?. Arch Neurol 60 (2003) 774-775
174. Rothwell P.M., Slattery J., and Warlow C.P. A systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Stroke 27 (1996) 260-265
175. Biller J., Feinberg W.M., Castaldo J.E., et al. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 97 (1998) 501-509
176. Chaturvedi S., Bruno A., Feasby T., et al. Carotid endarterectomy-an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 65 (2005) 794-801
177. Rothwell P.M., Eliasziw M., Gutnikov S.A., Warlow C.P., and Barnett H.J. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 363 (2004) 915-924
178. Bockenheimer S.A., and Mathias K. Percutaneous transluminal angioplasty in arteriosclerotic internal carotid artery stenosis. Am J Neuroradiol 4 (1983) 791-792
179. Theron J., Raymond J., Casasco A., and Courtheoux F. Percutaneous angioplasty of atherosclerotic and postsurgical stenosis of carotid arteries. Am J Neuroradiol 8 (1987) 495-500
180. Theron J., Courtheoux P., Alachkar F., Bouvard G., and Maiza D. New triple coaxial catheter system for carotid angioplasty with cerebral protection. Am J Neuroradiol 11 (1990) 869-874
181. Wiggli U., and Gratzl O. Transluminal angioplasty of stenotic carotid arteries: case reports and protocol. Am J Neuroradiol 4 (1983) 793-795
182. Diethrich E.B., Ndiaye M., and Reid D.B. Stenting in the carotid artery: initial experience in 110 patients. J Endovasc Surg 3 (1996) 42-62
183. Marks M.P., Dake M.D., Steinberg G.K., Norbash A.M., and Lane B. Stent placement for arterial and venous cerebrovascular disease: preliminary experience. Radiology 191 (1994) 441-446
184. Roubin G.S., New G., Iyer S.S., et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation 103 (2001) 532-537
185. Kastrup A., Groschel K., Krapf H., et al. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke 34 (2003) 813-819
186. Wholey M.H., Al-Mubarek N., and Wholey M.H. Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv 60 (2003) 259-266
187. Theiss W., Hermanek P., Mathias K., et al. Pro-CAS: a prospective registry of carotid angioplasty and stenting. Stroke 35 (2004) 2134-2139
188. Bosiers M., Peeters P., Deloose K., et al. Does carotid artery stenting work on the long run: 5-year results in high-volume centers (ELOCAS Registry). J Cardiovasc Surg (Torino) 46 (2005) 241-247
189. White C.J., Iyer S.S., Hopkins L.N., Katzen B.T., and Russell M.E. Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results. Catheter Cardiovasc Interv 67 (2006) 503-512
190. Safian R.D., Bresnahan J.F., Jaff M.R., et al. Protected carotid stenting in high-risk patients with severe carotid artery stenosis. J Am Coll Cardiol 47 (2006) 2384-2389
191. Gray W.A., Hopkins L.N., Yadav S., et al. Protected carotid stenting in high surgical risk patients: the ARCHeR results. J Vasc Surg 44 (2006) 258-268
192. Ramee S., and Higashida R. Evaluation of the Medtronic self-expanding carotid stent system with distal protection in the treatment of carotid artery stenosis: the MAVErIC Trial Phase II 30-day update. (abstr). Am J Cardiol 94 (2004) 61E
193. Hopkins LN. CABERNET. Oral presentation, EuroPCR Conference in Paris, France, May 26, 2005.
194. Gray WA. ARCHeR. Oral presentation, Amerian College of Cardiology Annual Scientific Session, Atlanta, GA, March 2006.
195. Naylor A.R., Bolia A., Abbott R.J., et al. Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial. J Vasc Surg 28 (1998) 326-334
196. Alberts M. Results of a multicenter prospective randomized trial of carotid artery stenting vs. carotid endarterectomy. (abstr). Stroke 32 (2001) 325d
197. Brooks W.H., McClure R.R., Jones M.R., et al. Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital. J Am Coll Cardiol 38 (2001) 1589-1595
198. Brooks W.H., McClure R.R., Jones M.R., et al. Carotid angioplasty and stenting versus carotid endarterectomy for treatment of asymptomatic carotid stenosis: a randomized trial in a community hospital. Neurosurgery 54 (2004) 318-324
199. Yadav J.S., Sneed D., Ouriel K., et al. Durability of carotid stenting for the prevention of stroke: 3-year follow-up of the SAPPHIRE trial and the US Carotid Feasibility. (abstr). Circulation 112 Suppl:II (2005) 416
200. Coward L.J., Featherstone R.L., and Brown M.M. Safety and efficacy of endovascular treatment of carotid artery stenosis compared with carotid endarterectomy: a Cochrane systematic review of the randomized evidence. Stroke 36 (2005) 905-911
201. Ringleb P.A., Kunze A., Allenberg J.R., et al. The Stent-Supported Percutaneous Angioplasty of the Carotid Artery vs. Endarterectomy Trial. Cerebrovasc Dis 18 (2004) 66-68
202. Ringleb P.A., Allenberg J.R., Bruckmann H., et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 368 (2006) 1215-1216
203. EVA-3S Investigators. Endarterectomy vs. Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial. Cerebrovasc Dis 18 (2004) 62-65
204. Mas J.L., Chatellier G., and Beyssen B. Carotid angioplasty and stenting with and without cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial. Stroke 35 (2004) e18-e20
205. Mas J.L., Chatellier G., Beyssen B., et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 355 (2006) 1726-1729
206. Featherstone R.L., Brown M.M., and Coward L.J. International carotid stenting study: protocol for a randomised clinical trial comparing carotid stenting with endarterectomy in symptomatic carotid artery stenosis. Cerebrovasc Dis 18 (2004) 69-74
207. Hobson R.W. CREST (Carotid Revascularization Endarterectomy versus Stent Trial): background, design, and current status. Semin Vasc Surg 13 (2000) 139-143
208. Hobson R.W., Howard V.J., Roubin G.S., et al. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg 40 (2004) 1106-1111
209. CARESS Steering Committee. Carotid revascularization using endarterectomy or stenting systems (CARESS): phase I clinical trial. J Endovasc Ther 10 (2003) 1021-1030
210. CaRESS Steering Committee. Carotid Revascularization Using Endarterectomy or Stenting Systems (CaRESS) phase I clinical trial: 1-year results. J Vasc Surg 42 (2005) 213-219
211. Schievink W.I. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med 344 (2001) 898-906
212. Cohen J.E., Leker R.R., Gotkine M., Gomori M., and Ben-Hur T. Emergent stenting to treat patients with carotid artery dissection: clinically and radiologically directed therapeutic decision making. Stroke 34 (2003) e254-e257
213. Houdart E., Mounayer C., Chapot R., Saint-Maurice J.P., and Merland J.J. Carotid stenting for radiation-induced stenoses: a report of 7 cases. Stroke 32 (2001) 118-121
214. Finsterer J., Strassegger J., Haymerle A., and Hagmuller G. Bilateral stenting of symptomatic and asymptomatic internal carotid artery stenosis due to fibromuscular dysplasia. J Neurol Neurosurg Psychiatry 69 (2000) 683-686
215. Sharma B.K., Jain S., Bali H.K., Jain A., and Kumari S. A follow-up study of balloon angioplasty and de-novo stenting in Takayasu arteritis. Int J Cardiol 75 Suppl 1 (2000) S147-S152
216. Roubin G.S., Iyer S., Halkin A., Vitek J., and Brennan C. Realizing the potential of carotid artery stenting: proposed paradigms for patient selection and procedural technique. Circulation 113 (2006) 2021-2030
217. Blacker D.J., Flemming K.D., Link M.J., and Brown Jr. R.D. The preoperative cerebrovascular consultation: common cerebrovascular questions before general or cardiac surgery. Mayo Clin Proc 79 (2004) 223-229
218. Stanziale S.F., Marone L.K., Boules T.N., et al. Carotid artery stenting in octogenarians is associated with increased adverse outcomes. J Vasc Surg 43 (2006) 297-304
219. Naylor A.R., Mehta Z., Rothwell P.M., and Bell P.R. Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature. Eur J Vasc Endovasc Surg 23 (2002) 283-294
220. Kasner S.E., Chimowitz M.I., Lynn M.J., et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 113 (2006) 555-563
221. Bush R.L., Lin P.H., Mureebe L., et al. Routine bivalirudin use in percutaneous carotid interventions. J Endovasc Ther 12 (2005) 521-522
222. Kapadia S.R., Bajzer C.T., Ziada K.M., et al. Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy. Stroke 32 (2001) 2328-2332
223. Wholey M.H., Wholey M.H., Eles G., et al. Evaluation of glycoprotein IIb/IIIa inhibitors in carotid angioplasty and stenting. J Endovasc Ther 10 (2003) 33-41
224. Rosenfield K., Babb J.D., Cates C.U., et al. Clinical competence statement on carotid stenting: training and credentialing for carotid stenting-multispecialty consensus recommendations: a report of the SCAI/SVMB/SVS Writing Committee to Develop a Clinical Competence Statement on Carotid Interventions. J Am Coll Cardiol 45 (2005) 165-174
225. Barr J.D., Connors III J.J., Sacks D., et al. Quality improvement guidelines for the performance of cervical carotid angioplasty and stent placement. J Vasc Interv Radiol 14 (2003) S321-S335
226. Beller G.A., Bonow R.O., and Fuster V. ACC revised recommendations for training in adult cardiovascular medicine. Core Cardiology Training II (COCATS 2). (Revision of the 1995 COCATS training statement). J Am Coll Cardiol 39 (2002) 1242-1246
227. Creager M.A., Goldstone J., Hirshfeld Jr. J.W., et al. ACC/ACP/SCAI/SVMB/SVS clinical competence statement on vascular medicine and catheter-based peripheral vascular interventions: a report of the American College of Cardiology/American Heart Association/American College of Physician Task Force on Clinical Competence (ACC/ACP/SCAI/SVMB/SVS Writing Committee to Develop a Clinical Competence Statement on Peripheral Vascular Disease). J Am Coll Cardiol 44 (2004) 941-957
228. Seymour N.E., Gallagher A.G., Roman S.A., et al. Virtual reality training improves operating room performance: results of a randomized, double-blinded study. Ann Surg 236 (2002) 458-463
229. Patel A., Gallagher A., Nicholson W., and Cates C.U. Learning curves and reliability measures for virtual reality simulation in the performance assessment of carotid angiography. J Am Coll Cardiol 47 (2006) 1796-1802